S100B and neuroleptic malignant syndrome: Plasma biomarkers of brain injury, such as brain‐derived neurotrophic factor (BDNF), glial‐fibrillary‐acidic protein(GFAP), and astrocytic‐protein‐S100B may be used for diagnosis and monitoring of foals with NMS.